Form 4: Clearwater Analytics CFO Reports Stock Transactions

Clearwater Analytics CFO James Cox reported the exercise of stock options and subsequent sale of shares, including tax-related withholdings, under a pre-arranged trading plan.

Summary

• James S. Cox, Chief Financial Officer of Clearwater Analytics Holdings, Inc. (CWAN), reported multiple transactions on August 15, 2025.
• Mr. Cox exercised 16,485 stock options at an exercise price of $4.4 per share.
• He disposed of 10,210 Class A Common Stock shares at a weighted average price of $19.4171 to cover tax withholding obligations related to the option exercise; this sale was mandated by the Issuer.
• An additional 6,275 Class A Common Stock shares were sold at a weighted average price of $19.4171.
• Another 5,000 Class A Common Stock shares were sold at a weighted average price of $19.4128.
• All sales were conducted pursuant to a Rule 10b5-1 trading plan adopted by Mr. Cox on March 11, 2024.
• Following these transactions, Mr. Cox directly beneficially owns 343,964 Class A Common Stock shares.
• He also retains beneficial ownership of 304,988 derivative securities (stock options).

Sentiment

Score: 6

Explanation: The transactions are routine for an insider exercising options and managing their equity, especially given the pre-arranged 10b5-1 plan and tax withholding. The significant gain from option exercise is positive for the insider, while the sales are expected and not indicative of negative sentiment towards the company.

Positives

• The exercise of stock options at a low price ($4.4) and subsequent sale at a significantly higher price (around $19.4) indicates a substantial personal gain for the CFO, reflecting the company's stock appreciation.
• The sales were pre-arranged under a Rule 10b5-1 trading plan, indicating a planned, non-discretionary transaction rather than a reaction to new negative information.
• A portion of the sales (10,210 shares) was specifically for tax withholding, which is a routine and non-discretionary event for option exercises.

Negatives

• The net effect of the transactions is a reduction in the CFO's direct holdings of Class A Common Stock by 5,000 shares (16,485 acquired 10,210 tax 6,275 sale 5,000 sale = -5,000). While common, insider selling can sometimes be viewed negatively by investors.

Risks

• While the sales were pre-planned, a consistent pattern of insider selling, even under 10b5-1 plans, could potentially be misinterpreted by some investors as a lack of confidence, though this single filing does not suggest such a pattern.
• Market perception risk if investors do not fully understand the routine nature of 10b5-1 plans and tax-related sales.

Future Outlook

This filing, a Form 4, reports past insider transactions and does not contain forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing details routine insider stock transactions, specifically an option exercise and subsequent sales under a pre-arranged plan. It does not provide information directly related to broader industry trends or competitive positioning, focusing solely on the individual's equity holdings and transactions within Clearwater Analytics Holdings, Inc.

Stakeholder Impact

• Shareholders may note the insider's stock transactions, but given they were conducted under a Rule 10b5-1 plan and included tax-related sales, the impact on investor sentiment is likely minimal as they are considered routine.

Key Dates

Recommendation

This Form 4 filing details routine insider stock transactions, specifically an option exercise and subsequent sales under a pre-arranged Rule 10b5-1 plan, including shares sold for tax withholding. Such transactions are generally not indicative of new fundamental information about the company's performance or outlook and therefore do not warrant a change in investment recommendation. The significant personal gain from the option exercise is a positive for the insider, but the overall activity is expected and does not suggest a shift in the company's prospects.

Keywords

Clearwater Analytics, CWAN, Form 4, Insider Trading, Stock Option Exercise, Share Sale, CFO, Rule 10b5-1